Search

everythinglearnresearchcommunity

for

Search:↓

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

Topical PUVA can cause temporary hair regrowth in some alopecia areata patients but doesn't change the long-term outcome.

Alopecia areata patients have more Propionibacterium acnes and less Staphylococcus epidermidis on their scalps.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Narrowband UVB phototherapy alone is not very effective for treating alopecia areata.

Diphencyprone (DPC) is an effective and safe long-term treatment for alopecia areata, especially with maintenance therapy.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Children with alopecia areata should only have thyroid screening if they have Down syndrome, a history of atopy, family history of thyroid disease, or signs of thyroid problems.

Systemic corticosteroids don't prevent severe alopecia areata from spreading or relapsing.

Quercetin effectively treated and prevented hair loss in mice.

The combined therapy was effective and safe for children with severe alopecia areata.

Vitamin D levels do not affect the risk of developing alopecia areata.

People with alopecia areata have a higher risk of depression and anxiety, and often face unemployment and work absences.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Topical immunotherapy can treat alopecia areata, but its effectiveness varies and the exact mechanism is unclear.

Combining DPCP and anthralin helps regrow hair in some alopecia areata patients.

Monthly oral corticosteroid pulses effectively treat widespread alopecia areata in young patients.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

Alopecia Areata is an autoimmune disease causing hair loss in patches, often starting before age 20, and while some cases recover on their own, treatments include topical corticosteroids, minoxidil, and promising new methods like IL-31 antibodies and 308-nm Excimer laser therapy.

Oxidative stress plays a significant role in alopecia areata, and new treatments may include JAK inhibitors and antioxidants.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Yellow dots are common in severe alopecia areata.

Corticosteroid pulse therapy is more effective for severe alopecia areata than combination therapy.

Alopecia areata greatly affects people's life quality, mental health, and work life.

The C-allele and CC-genotype in the PTPN22 gene lower the risk of alopecia areata.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Stress can trigger or worsen alopecia areata.